Patentamiento de anticuerpos monoclonales: El caso de Argentina
Patentamiento de anticuerpos monoclonales: El caso de Argentina
This research paper aims to identify, describe and analyze the patents on monoclonal antibodies granted by the National Institute of Industrial Property (INPI) of Argentina, from 2010 to 2020 inclusive. The research includes the protected subject matter and the universe of applicants, among other aspects. To this end, a database of patents and applications was created, where the characteristics of the patent applications and granted patents, ownership and nationality of the applicants, status of the applications, the time it takes to process a patent application and divisional patents are examined. The document also presents recommendations on public policy applicable to the examination of patent applications on monoclonal antibodies.
Biosimilars, ddc:300, Access to Medicines, Argentina, Patent, Biologicals, Public Health, Biologics, Intellectual Property, Biopharmaceuticals, Monoclonal Antibodies
Biosimilars, ddc:300, Access to Medicines, Argentina, Patent, Biologicals, Public Health, Biologics, Intellectual Property, Biopharmaceuticals, Monoclonal Antibodies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!